文献速递关节外科

用于确定全膝关节置换术后再入院风险的术前量表

A Preoperative Scale for Determining Surgical Readmission Risk After Total Knee Arthroplasty.
PubMed 文献 · J Bone Joint Surg Am · 2017-01-01

基于纽约和加利福尼亚433638例及佛罗里达和华盛顿269934例全膝关节置换患者出院数据,开发并验证再入院风险量表RATKA。推导队列和验证队列30天再入院率分别为5.11%和4.98%。RATKA评分将风险分为低(<13分,再入院率3.7%)、中(13-16分,5.4%)、高(>16分,7.6%)三级,高风险组较低风险组再入院相对风险为2.06。

要点

  • RATKA量表基于年龄、性别、种族、支付方式及合并症等术前因素构建。
  • 低风险(<13分)再入院率3.7%,中风险(13-16分)5.4%,高风险(>16分)7.6%。
  • 高风险组较低风险组再入院相对风险为2.06。

核心结论

  • 推导队列得出的RATKA量表能以>95%的比率可靠解释验证队列中全膝关节置换术后再入院的变异性。
  • RATKA量表等模型能够基于患者术前风险特征识别全膝关节置换术后再入院风险。

研究设计与样本

  • 回顾性队列研究,数据来源于州住院患者数据库(医疗成本与利用项目,2006年至2011年)。
  • 推导队列为纽约和加利福尼亚的433638例全膝关节置换患者,验证队列为佛罗里达和华盛顿的269934例全膝关节置换患者。
  • 提取患者人口学和临床特征进行分析,开发再入院风险量表RATKA。

主要发现

  • 推导队列30天再入院率为5.11%,验证队列为4.98%。
  • 推导队列中与30天再入院率增加显著相关的因素包括:年龄41-50岁(OR=1.13)、年龄71-80岁(OR=1.21)、年龄81-90岁(OR=1.70)、男性(OR=1.19)、非裔美国人种族(OR=1.37)、其他种族/族裔(OR=1.08)、医疗补助支付方(OR=1.43)、医疗保险支付方(OR=1.27)、贫血(OR=1.19)、慢性阻塞性肺疾病(OR=1.29)、凝血功能障碍(OR=1.22)、充血性心力衰竭(OR=1.64)、糖尿病(OR=1.19)、液体和电解质紊乱(OR=1.25)、高血压(OR=1.10)、肝病(OR=1.27)、肾衰竭(OR=1.33)、类风湿关节炎(OR=1.14)。
  • RATKA评分定义3个再入院风险等级:低风险(RATKA评分<13分;再入院率3.7%)、中风险(RATKA评分13-16分;再入院率5.4%)、高风险(RATKA评分>16分;再入院率7.6%)。
  • 高风险组较低风险组再入院的相对风险为2.06。

关键数值与推荐

  • RATKA评分<13分为低风险,再入院率3.7%。
  • RATKA评分13-16分为中风险,再入院率5.4%。
  • RATKA评分>16分为高风险,再入院率7.6%。
  • 高风险组较低风险组再入院相对风险为2.06。

临床怎么用

  • RATKA量表可在术前基于患者风险特征识别全膝关节置换术后再入院风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Total knee arthroplasty (TKA) is one of the most common orthopaedic procedures performed in the U.S. The purpose of this study was to develop and verify a scale to preoperatively stratify a patient's risk of being readmitted to the hospital following a TKA. METHODS: Discharge data on 433,638 patients from New York and California (derivation cohort) and 269,934 patients from Florida and Washington (validation cohort) who underwent TKA were collected from the State Inpatient Database, a part of the Healthcare Cost and Utilization Project of the Agency for Healthcare Research and Quality (2006 to 2011). Demographic and clinical characteristics of patients were abstracted and analyzed to develop the Readmission After Total Knee Arthroplasty (RATKA) Scale. RESULTS: Overall 30-day readmission rates in the derivation and validation cohorts were 5.11% and 4.98%, respectively. The following factors were significantly associated with increased 30-day readmission rates in the derivation cohort: age of 41 to 50 years (odds ratio [OR] = 1.13), age of 71 to 80 years (OR = 1.21), age of 81 to 90 years (OR = 1.70), male sex (OR = 1.19), African-American race (OR = 1.37), "other" race/ethnicity (OR = 1.08), Medicaid payer (OR = 1.43), Medicare payer (OR = 1.27), anemia (OR = 1.19), chronic obstructive pulmonary disease (OR = 1.29), coagulopathy (OR = 1.22), congestive heart failure (OR = 1.64), diabetes (OR = 1.19), fluid and electrolyte disorder (OR = 1.25), hypertension (OR = 1.10), liver disease (OR = 1.27), renal failure (OR = 1.33), and rheumatoid arthritis (OR = 1.14). These factors were used to create the RATKA Scale. The RATKA score was then used to define 3 levels of risk for readmission: low (RATKA score of <13; 3.7% readmission rate), moderate (RATKA score of 13 to 16; 5.4% readmission rate), and high (RATKA score of >16; 7.6% readmission rate). The relative risk of readmission was 2.06 for the high-risk group compared with the low-risk group. CONCLUSIONS: The RATKA Scale derived from patient data from the derivation cohort was reliably able to explain readmission variability after TKA for patients in the validation cohort at a rate of >95%. Models such as the RATKA Scale will enable identification of the risk of readmission following TKA based on a patient's risk profile prior to surgery. LEVEL OF EVIDENCE: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Siracuse BL, Ippolito JA, Gibson PD, et al. A Preoperative Scale for Determining Surgical Readmission Risk After Total Knee Arthroplasty. J Bone Joint Surg Am. 2017. PMID: 29088044. doi:10.2106/JBJS.16.01043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。